Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
shivan.sivakumar@oncology.ox.ac.uk

Shivan Sivakumar

Honorary Departmental Academic Clinical Lecturer

Recent publications

Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound.

Spiers L. et al, (2023), BMC Cancer, 23

Immune responses in pancreatic cancer may be restricted by prevalence of activated regulatory T-cells, dysfunctional CD8+ T-cells, and senescent T-cells

Sivakumar S. et al, (2020)

The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19.

UK Coronavirus Cancer Monitoring Project team ., (2020), Lancet Oncol, 21, 622 - 624

The T-cell architecture of pancreatic ductal adenocarcinoma

Sivakumar S. et al, (2019), Cancer Research, 79

Tumor heterogeneity: does it matter?

Turnquist C. et al, (2019), Expert Rev Anticancer Ther, 19, 857 - 867

More publications